Stockscreener 앱 받기
166.75
0.59%
-0.99
시간 외 거래:
166.75
Ligand Pharmaceuticals Inc 주식(LGND)의 최신 뉴스
Is Ligand Pharmaceuticals Incorporated stock poised for growthPortfolio Risk Summary & Real-Time Market Trend Scan - Newser
Is Ligand Pharmaceuticals Incorporated stock bottoming outJuly 2025 Final Week & Real-Time Stock Price Movement Reports - Newser
Using data models to predict Ligand Pharmaceuticals Incorporated stock movement2025 Biggest Moves & Precise Entry and Exit Recommendations - Newser
Published on: 2025-09-05 14:36:20 - Newser
What is Ligand Pharmaceuticals Incorporated s revenue forecastMarket Growth Review & AI Powered Trade Plan Recommendations - خودرو بانک
Advanced analytics toolkit walkthrough for Ligand Pharmaceuticals IncorporatedJuly 2025 Movers & Smart Swing Trading Techniques - Newser
Can Ligand Pharmaceuticals Incorporated reach all time highs this yearWeekly Risk Report & AI Forecasted Stock Moves - خودرو بانک
Can Ligand Pharmaceuticals Incorporated withstand a market correctionRisk Management & Intraday High Probability Alerts - خودرو بانک
Published on: 2025-09-05 01:53:48 - Newser
Will Ligand Pharmaceuticals Incorporated see short term momentum2025 Market Outlook & Weekly High Momentum Picks - Newser
What is Ligand Pharmaceuticals Incorporated’s TAM (Total Addressable Market)2025 Buyback Activity & Reliable Entry Point Trade Alerts - خودرو بانک
Is Ligand Pharmaceuticals Incorporated part of any major index2025 Performance Recap & Long-Term Safe Investment Plans - خودرو بانک
Insider Sell: John Kozarich Sells Shares of Ligand Pharmaceutica - GuruFocus
Is this a good reentry point in Ligand Pharmaceuticals IncorporatedTrade Analysis Report & Low Drawdown Investment Strategies - Newser
How to build a dashboard for Ligand Pharmaceuticals Incorporated stockJuly 2025 Analyst Calls & Community Trade Idea Sharing Platform - Newser
Ligand Pharmaceuticals (LGND) director Kozarich sells $76k in stock - Investing.com
Ligand Pharmaceuticals (LGND) director Kozarich sells $76k in stock By Investing.com - Investing.com UK
Ligand Pharmaceuticals Director Sells 467 Shares Between $161.51 and $164.25/Share - AInvest
Volume spikes in Ligand Pharmaceuticals Incorporated stock – what they meanEntry Point & Real-Time Buy Signal Alerts - Newser
Published on: 2025-09-04 06:48:32 - Newser
Custom watchlist performance reports with Ligand Pharmaceuticals Incorporated2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
Will Ligand Pharmaceuticals Incorporated continue its uptrendPortfolio Update Summary & Community Consensus Trade Alerts - Newser
Will Ligand Pharmaceuticals Incorporated outperform the market in YEAREarnings Growth Report & Weekly High Potential Stock Alerts - خودرو بانک
Using Python tools to backtest Ligand Pharmaceuticals Incorporated strategiesShare Buyback & Scalable Portfolio Growth Ideas - Newser
Oppenheimer Raises Ligand Pharmaceuticals (LGND) Price Target to $190 | LGND Stock News - GuruFocus
Real time pattern detection on Ligand Pharmaceuticals Incorporated stockWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Oppenheimer Adjusts Price Target on Ligand Pharmaceuticals to $190 From $167, Maintains Outperform Rating - MarketScreener
Can volume confirm reversal in Ligand Pharmaceuticals Incorporated2025 Support & Resistance & Verified Short-Term Trading Plans - Newser
Custom strategy builders for tracking Ligand Pharmaceuticals IncorporatedJuly 2025 Volume & Comprehensive Market Scan Reports - Newser
Will earnings trigger a reversal in Ligand Pharmaceuticals Incorporated2025 Price Action Summary & Consistent Profit Focused Trading Strategies - Newser
Aug Levels: What is the next catalyst for Ligand Pharmaceuticals IncorporatedQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Benchmark Reaffirms Buy Rating on Ligand with Raised PT to $175. - AInvest
Ligand price target raised to $175 from $160 at Benchmark - TipRanks
Applying Wyckoff theory to Ligand Pharmaceuticals Incorporated stockMarket Rally & Weekly Market Pulse Updates - Newser
Is Ligand Pharmaceuticals Incorporated attractive for institutional investorsLong Setup & Short-Term Trading Opportunity Alerts - خودرو بانک
Can Ligand Pharmaceuticals Incorporated rally from current levelsProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Heatmap analysis for Ligand Pharmaceuticals Incorporated and competitorsJuly 2025 Snapshot & Capital Efficient Trading Techniques - Newser
1.40%
자본화:
|
볼륨(24시간):